Tempest Therapeutics (TPST) Acquisitions (2018)
Tempest Therapeutics' (TPST) quarterly Acquisitions came in at $524000.0 in Q1 2018.
Powered by 
Analysis
Tempest Therapeutics (TPST) Acquisitions (2018) Analysis & Trends
Tempest Therapeutics has disclosed Acquisitions across 1 years of filings, most recently posting $524000.0 for Q1 2018.
- In Q1 2018, Acquisitions changed N/A year-over-year to $524000.0; the TTM figure through Dec 2018 stood at $524000.0 (changed N/A YoY), while the FY2018 annual figure was $524000.0, up 213.42% from the prior year.
- Acquisitions came in at $524000.0 for Q1 2018 at Tempest Therapeutics.
- In the past five years, Acquisitions ranged from a high of $524000.0 in Q1 2018 to a low of $524000.0 in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - | - |